Paclitaxel for second-line treatment of squamous cell carcinoma of the head and neck: A multicenter retrospective Italian study

doi:10.5306/wjco.v15.i12.1468

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (242)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-6) series.

Item

Count

PDF

HTML

Figures (1-3)

Tables (1-6)

Sum=126

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=89

Publishing Process of This Article

Item

Count

Browse

Download

Sum=18

Dec 24, 2024 (publication date) through Oct 28, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Oncol. Dec 24, 2024; 15(12): 1468-1480
Published online Dec 24, 2024. doi: 10.5306/wjco.v15.i12.1468

Full Size Figure Download Figure

Figure 3 Median progression-free survival rates according to stratification parameters. A: Median progression-free survival (PFS) in the smoking group; B: Median PFS in the alcohol consumption subgroup; C: Median PFS in the body mass index subgroup. PFS: Progression-free survival; BMI: Body mass index.

Citation: Fasano M, Pirozzi M, Vitale P, Damiano V, Ronzino G, Farese S, Carfora V, Ciccarelli G, Di Giovanni I, Facchini S, Cennamo G, Caraglia M, Ciardiello F, Addeo R. Paclitaxel for second-line treatment of squamous cell carcinoma of the head and neck: A multicenter retrospective Italian study. World J Clin Oncol 2024; 15(12): 1468-1480
URL: https://www.wjgnet.com/2218-4333/full/v15/i12/1468.htm
DOI: https://dx.doi.org/10.5306/wjco.v15.i12.1468